Novartis Investigative Site
El Metn
0 studies enrolling now · 1 studies all time
What they study most
Triple-negative Breast Cancer
Studies at this site
A Study of Efficacy and Safety of LAG525 in Combination With Spartalizumab, or With Spartalizumab and Carboplatin, or With Carboplatin, in Patients With Advanced Triple-negative Breast Cancer
— Completed